Condition
Splenomegaly clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Splenomegaly clinical trials that are recruiting, at sites in 2 countries (most in United States (1), France (1)). By phase: Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Screening for ASMD in people with diffuse interstitial lung disease
This study tests a screening algorithm to see if people with diffuse ILD, who may have ASMD, actually have the disease by measuring acid sphingomyelinase activity and LysoSM in a 200-person cohort.
-
Using high doses of ruxolitinib and stem cell transplant for myelofibrosis patients with enlarged spleens
This study is testing if giving high doses of ruxolitinib and busulfan before a stem cell transplant can help people with myelofibrosis and enlarged spleens live longer and have better recovery after the transplant.
Related topics
Quick answers
How many Splenomegaly clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), France (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.